Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3918452 A
Publication typeGrant
Publication dateNov 11, 1975
Filing dateAug 1, 1974
Priority dateAug 1, 1974
Publication numberUS 3918452 A, US 3918452A, US-A-3918452, US3918452 A, US3918452A
InventorsCornfeld Edward
Original AssigneeCornfeld Edward
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Tampons impregnated with contraceptive compositions
US 3918452 A
Abstract
Vaginal sponges and/or tampons impregnated with contraceptive compositions and methods of preventing conception or implantation by insertion in an animal organism of said sponge or tampon prior to exposure to conception.
Images(1)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

United States Patent 1191 Cornfeld [451 Nov. 11, 1975 [5 1 TAMPONS IMPREGNATED WITH 3.108.043 10/1963 Somerville 128/270 I CONTRACEPTIVE COMPOSITIONS 3.108043 10/1963 Mi11man 128/270 X 3,424,159 1/1969 Whitehead at 211.... 128/263 1 Inventorl Edward Potomac, 3.490.454 1/1970 G01df2ll'b et a1 128/285 3.521637 7/1970 Waterbury 1 128/270 [73] Asslgnee' ai S'lver Spnng 3.639562 2/1972 Gordon et Z11..... 128/270 x 3,679,102 7/1972 Charle 1 1 128/260 X [22] i Aug 1 974 3,749,094 7/1973 Duncan 128/270 3,756,238 9/1973 Hanke.... 128/270 [21] Appl. No: 493,831 3,850,173 11/1974 Dash 128/261 152 US. Cl. 128/270; 128/260; 128/263 i' Medbery 424/16 Attorney, Agent, or Firm-Sherman & Shalloway [51] Int. Cl. A61F 13/20; A61K 7/00 [58] Field of Search 128/260, 270, 285, 290 R, [57] ABSTRACT 261; 424/16 45 Vaginal sponges and/or tampons impregnated with contraceptive compositions and methods of prevent- [56] References Clted ing conception or implantation by insertion in an ani- UNITED STATES PATENTS mal organism of said sponge or tampon prior to expo- 702,570 6/1902 Lohlein 128/263 sure to conception. 2,943,979 7/1960 Elias 424/16 3.091.241 5/1963 K6116 128/270 3 Clams, 5 Drawlng Figures US. Patent Nov. 11, 1975 FIG.4

FIGJ

FIG.5

TAMPONS IMPREGNATED WITH CONTRACEPTIVE COMPOSITIONS BACKGROUND OF THE INVENTION DESCRIPTION OF THE PRIOR ART It has long been an object of the pharmaceutical industry to discover a safe and'effective method of preventing conception which can be utilized precoitus that is non-interfering and easy to use.

Heretofore, it has been known to impregnate tampons with an abortive facient, such as pi'ostaglandin, in order to terminate a conception in the very early states of the pregnancy.

Additionally, prior art methods are known for preventing conception by utilization of vaginal foams or creams containing cont'faceptive compositions. The prior art means of preventing conception are either inconvenient to use or have physiological or psychological drawbacks once pregnancy has begun.

U.S. Pat. No. 3,105,128 shows a method of microencapsulation.

U.S. Pat. No. 3,691,271 shows a sanitary napkin with microcapsules filled with a bactericidal and fungicidal deodorant.

U.S. Pat. No. 3,814,809 shows the combination of a suppository and tampon with a contraceptive drug for use after exposure.

I SUMMARY OF THE PRESENT INVENTION It is a general feature of the present invention to avoid and overcome the foregoing and other difficulties and objections to prior art contraceptive means by the provision of a more effective and generally acceptable means. More specifically, a feature of the present invention is to provide a vaginal sponge or tampon which is impregnated with a known safe and effective contra ceptive composition.

Further, another feature of the present invention is to provide a vaginal sponge or tampon which is impregnated with a contraceptive drug that is microencapsulated so that there is a sustained release of the contraceptive composition before, during and/or after coitus.

It is still another feature of the present invention to provide a means for insertion of the sponge or tampon into the vagina which can be packaged as a single unit.

A yet further feature of the present invention is to provide a means for housing the impregnated sponge or tampon, inserting the sponge or tampon and, if desired, removing the sponge or tampon from the vagina.

The aforesaid features of the present invention, and other features which will become apparent as the description proceeds, are accomplished by providing a vaginal sponge or tampon that is impregnatedupreferably 'a microencaptlital eenrrlce snve cameos:

' sules which maybe used are those which provide a sustained release and/or those which are pressure rupturable. The contraceptive composition may include any of the known steroidal or non-steroidal compounds.

A method having certain features of this invention includesthe step of inserting and maintaining in the vagina a sponge or tampon impregnated with a contraceptive composition, preferably a composition which is microencapsulated.

DETAILED DESCRIPTION OF THE PRESENT INVENTION For a better understanding of the present invention, reference should be made to the accompanying drawings,. wherein like numerals indicate similar parts throughout the several views and wherein:

FIG. 1 isa perspective view of a tampon and applicator inaccordance with this invention. I

FIG. 2 isa perspective view of a further applicator and tampon of the present invention.

FIG. 3 is a perspective view of a tampon of this invention. p

FIG. 4 is a cross-sectional view of the impregnated tampon of FIG. 3

FIG. 5 is a cross-sectional view of an impregnated sponge having aspring means.

PREFERRED EMBODIMENTS OF THE PRESENT I INVENTION able in the housing 12 so as to eject the tampon 14 from the housing 12. If the tampon 14 is provided with a means for removal, such as a string 19, the housing 12 may be provided with'a slot 18 so as to accommodate the string. V

FIG. 2 illustrates a further embodiment of the invention wherein there is provided an applicator 20 having a housing 28 containing an impregnatedtampon 24 in the front end portion. The applicator 20 is provided with a plunger 26 which ejects the tampon 24 and is capable of providing a vacuum suction so as to withdraw the tampon when desired. x

FIG. 3 shows the tampon prior to compression and insertion into the applicator shown in FIG. 1. The tampon comprises any of the known cellulosic tampons that are well known in the art. The tampon includes those which contain the conventional polyurethane foams, the reaction product of liquid polyols (polyester or polyether) and a disfunctional isocyanate, usually toluene diisocyanate. A catalyst such as tin, an ammine, a flowing agent, generally water, and foaming stabilizers are also employed. The required cylinders for tampon use are cut from the prepared foam. The string 19 is provided for removal of the tampon either preor post-coitus FIG. 4 is a cross-sectional view of the tampon of FIG. 3 showing the microencapsulations 40 The microcapsules used in the present: invention uahrbe madeabf any Beaver-newly mplayea material in :the mieroefic apwanna new; -Represenmive of polymeric mataria-ls to prcs'anee- @He--mi@f6capsules aresuellz polymfli's an polymyimeehol, pdlyerh ylene, polypropylene. polystyrilefpolyatrylamidesg polyethers; pdlyestehs; polyamides, polybutadiene, polyisoprene, epoxy resins, polyurethanes, ethyl cellulose, carboxymethyl cellulose and the like. The nature and the size of the walls will be generally chosen for their compatibility with the contraceptive composition used. Generally, the ratio of the weight of the wall to the total weight of the filled microcapsule ranges from between 3-10:100.

Any conventional technique of microcapsule fabrication can be used, particularly microencapsulation by mechanical means such as centrifugal microencapsulatioh. In this method, droplets of the material to be microencapsulated are formed by the centrifugal force of a turntable which then traverse by means of the velocity with which they thus acquire a thin film of fluid product designed to form the wall of the microcapsule. Conventional wall-hardening treatment can be employed which, in a case where the wall is prepared from a thermoplastic material, can simply be a sudden cooling of the microcapsules formed. Representative suitable microencapsulation operation can be found in the literature, for instance U.S. Pat. No. 3,015,128.

The material encapsulated in the microcapsules can be, for instance, such contraceptive compounds as nonylphenoxypolyethoxyethanol and an estrongenic compound such as 3-methoxy-19-nor-170z-pregna- 1,3,5( l)-trien-20-yn-17-o1; l9-nor-17oz-pregn-4-enyne-l3B, 17 diol and the like.

FIG. is a cross-sectional view of a vaginal sponge 50 which comprises preferably a cellular resilient material 52 having therein a spring 54 for maintaining the sponge in an expanded state. The sponge 52 may comprise any of the known water-resistant cellular matter such as cellulosic sponge, polyurethane, polyesters, and the like which are compatible with the body. The sponge 50 contains throughout the microcapsules 40 containing the contraceptive material. The size and composition of the capsule wall is preferably varied in solubility and rupturability so as to provide a sustained release during usage. Additionally, the microcapsules may contain in addition to the contraceptive compositions any spermicide which is known in the art. The microencapsulation permits the utilization of known compatible compositions simultaneously.

The method in accordance with this invention comprises inserting in the animal organism one vaginal tampon which is impregnated with a contraceptive composition and/or spermicidal composition between one hour and twenty-four hours prior to exposure. As stated above, the contraceptive has a sustained release in the vagina during and after coitus so that any exteriorally inserted fluids, such as semen resulting from coitus, will be exposed to the contraceptive compositions and any accompanying spermicide released by the rupturability and solubility of the micro capsules 40 in the normal muscosa fluid present in the vagina.

Obviously, the dosage form will depend upon the contraceptive composition employed, besides that the microcapsules generally have a size ranging from about 50 1,000 microns in diameter. The thickness of the wall of the microcapsule will vary according to the materials used and to the effect desired,

The microcapsules are introduced either directly into the sponge or tampon at a moment-in which its fluidity porate them before termination of the polymerization of the sponge.

In general, microcapsules are introduced into the sponge or tampon in the course of manufacture in the form of a liquid or suspension; the best possible homogenization is obtained by suitable mixing by agitation, shaking or blowing in of a gas. The density of the liquid or of the suspension is then adjusted to that of the microcapsules by addition of a suitable inert substance. It is also possible to select microcapsules whose density corresponds to that of the liquid or suspension at the time of their introduction into the sponge or tampon. The following non-limiting examples, in which parts and percentages refer to weight, are given by way of illustration and allow a fuller understanding of the present invention.

EXAMPLE 1 Tampon containing a microencapsulated contraceptive composition:

The following contraceptive composition is prepared:

Contraceptive Compound 4.0 Vaseline 6.0 Glycerol 10.0 Anti-ferment 0.1 Water to make-up 100.0

The contraceptive composition is then microencapsulated by the known technique, using polypropylene, the microcapsules having an average diameter of 50-100 microns and preferably 60-80 microns. Microcapsules are dispersed either by a suitable mechanical device or by projection using compressed air or gas.

The contraceptive compound may be any of the known estrogenic agents such as Enovid (Trademark).

EXAMPLE 11 The sponge containing microencapsulated contraceptive composition:

The following solution is prepared:

Glycerin 5.00 Contraceptive Compound 10.00 Oxytoxin 0.50

EXAMPLE 111 The following composition is prepared:

Spermicide 10.00 Gl yrine 10.00 Sodium Lauryl SulfateSolution (30%) 30.00

This composition containing-- the spermicide; is thh microencapsulated utilizing p e lyyiay l 'a uhalfiay any positions, the vaginal sponge or tampon may be surface coated or impregnated with a contraceptive composition dissolved or suspended in a melt of a low-melting, biodegradable wax. The 'wax with the contraceptive compound incorporated is then either powdered or the melt is poured over a cold surface and a waxy material scraped off in the forms of powder or flakes. Among the vehicles for slow release of the contraceptive composition in biological fluids are acetyl palmitate, carbona wax, lauric acid, a mixture of sodium laurate and lauric acid, a mixture of stearic acid and sodium stearate, a mixture of archidonic acid and sodium archidonate and acetyl palmitate.

Obviously, the embodiments shown are exemplary only and a wide variety of embodiments may be devised without departing from the spirit and scope of the invention.

What is claimed is:

l. The method of preventing conception or implantation which comprises inserting into the vagina of a mammal a sponge tampon impregnated with microcapsules having a contraceptive composition prior to exposure to exteriorally inserted fluids and permitting said sponge tampon to remain in the vagina until at least an effective amount of said composition is released and leaving the sponge tampon in the vagina at least during the insertion of said exterior fluids so as to prevent conception or implantation from said fluids.

2. The method of claim 1 wherein said comosition is microencapsulated in a sustained release form and said composition is caused to be released by the biological muscosa fluid.

3. The method of claim 1 wherein said microcapsules include a spermicide and said spermicide is released with said contraceptive composition.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US702570 *Aug 1, 1901Jun 17, 1902Leonard J LohleinCombined applicator and syringe.
US2943979 *Jun 23, 1959Jul 5, 1960Nathaniel M EliasConcentrated foam-producing spermicides
US3091241 *Aug 26, 1959May 28, 1963Kimberly Clark CoVaginal tampon
US3108043 *May 9, 1960Oct 22, 1963Ortho Pharma CorpSpermicidal sheet-like material
US3424159 *Dec 12, 1966Jan 28, 1969Kimberly Clark CoTampon insertion device
US3490454 *Oct 21, 1966Jan 20, 1970United Merchants & MfgCatamenial products having a coating of rupturable microcapsules containing medicants
US3521637 *Nov 28, 1967Jul 28, 1970Haskett Barry FTampon or similar sanitary napkin containing vitamin a
US3639562 *Apr 29, 1970Feb 1, 1972Smith Kline French LabVaginal suppositories and impregnated tampons
US3679102 *Feb 4, 1970Jul 25, 1972OrealAerosol composition and method for producing same
US3749094 *Aug 18, 1971Jul 31, 1973Procter & GambleTampon with string attached to its proximal end
US3756238 *Mar 24, 1971Sep 4, 1973Kimberly Clark CoSelf-lubricating compound for use in hygienic and medical applications, and coated tampons and suppositories made therefrom
US3850173 *Apr 30, 1973Nov 26, 1974American Home ProdFlushable vaginal applicator
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US4186742 *Jun 9, 1978Feb 5, 1980Donald Enterprises, Inc.Contraceptive-antivenereal disease tampon
US4271835 *May 17, 1978Jun 9, 1981Kcdp CorporationFluid-expansible contraceptive tampon and applicator
US4309997 *Mar 24, 1980Jan 12, 1982Donald Jack WPorous foam ball containing germicidal agent
US4318405 *Jul 24, 1980Mar 9, 1982Sneider Vincent RTampon and drug delivery device
US4351338 *May 21, 1980Sep 28, 1982Pierre LangloisA sponge material impregnated(no pun intended) with a spermicidal composition in a time release medium
US4393871 *Mar 30, 1981Jul 19, 1983Vli CorporationVaginal device
US4553965 *Jul 6, 1984Nov 19, 1985Shepard ConnFluid-expansible contraceptive tampon and applicator
US4585651 *Dec 18, 1980Apr 29, 1986Stolle Research & Development CorporationAntifertility vaccine
US4618496 *Jul 16, 1984Oct 21, 1986Johnson & JohnsonSoaking in heterocyclic compound; absorbers, hygienic and health products
US4645488 *Nov 30, 1983Feb 24, 1987Board Of Trustees Of The University Of AlabamaSyringe for extrusion of wetted, particulate material
US4732763 *Sep 28, 1984Mar 22, 1988Stolle Research And Development CorporationActive/passive immunization of the internal female reproductive organs
US4742820 *Sep 17, 1985May 10, 1988Hannegret LeuchtenbergerDevice for introducing a diaphragm
US5141515 *Oct 11, 1990Aug 25, 1992Eberbach Mark AApparatus and methods for repairing hernias
US5304187 *Jun 30, 1992Apr 19, 1994United States Surgical CorporationSurgical element deployment apparatus
US5366460 *Aug 24, 1992Nov 22, 1994Cook IncorporatedApparatus and method for laparoscope hernia repair
US5520669 *Jul 19, 1994May 28, 1996Mulholland; Kevin J.Intra-rectal drain and receptacle for fecal incontinence
US5527534 *Oct 21, 1993Jun 18, 1996Gynetech Laboratories, Ltd.User-controlled release of drug contained in saturated sponge. a truncated sphere or tampon; for delivering contraceptives, antibiotics, hormones, antiinflammatory agents or cleansing agents
US5741239 *May 24, 1996Apr 21, 1998Mulholland; Kevin J.Intra-rectal drain and receptacle for fecal incontinence
US6558362 *Feb 2, 2000May 6, 2003Bernard ChaffringeonDisposable device for transferring an active liquid into a body cavity
US6645136Sep 28, 2000Nov 11, 2003Kimberly-Clark Worldwide, Inc.Incontinence insert applicators and methods for their use
US6676594Sep 18, 2002Jan 13, 2004Kimberly-Clark Worldwide, Inc.C-shaped vaginal incontinence insert
US6695763Jan 2, 2002Feb 24, 2004Kimberly-Clark Worldwide, Inc.Incontinence insert device and method of using same
US6758840Apr 20, 2001Jul 6, 2004Metris Therapeutics LimitedDrug delivery device
US6770025Sep 18, 2002Aug 3, 2004Kimberly-Clark Worldwide, Inc.Molar shaped vaginal incontinence insert
US6808485Dec 23, 2002Oct 26, 2004Kimberly-Clark Worldwide, Inc.Compressible resilient incontinence insert
US6939289Oct 21, 2002Sep 6, 2005Kimberly-Clark Worldwide, Inc.Ellipitcal applicator system
US7004171Feb 25, 2002Feb 28, 2006Hi-Gienic Intra Vaginal Technologies Ltd.System for transvaginal drug delivery
US7044928Apr 4, 2003May 16, 2006Platex Products, Inc.Tampon applicator assembly having an improved plunger and methods of making
US7091395 *Jun 2, 2003Aug 15, 2006Jean-Bastien PasquiniAntiseptic tampon and method of preparing it
US7128925Feb 2, 2001Oct 31, 20063X EngineeringDevice for applying active principles for pharmaceutical or cosmetic purposes
US7186248 *Aug 16, 2002Mar 6, 2007Peter James Brian LambDevice for introducing an object into a vagina with sanitary finger mounting means
US7527614Mar 25, 2005May 5, 2009Kimberly-Clark Worldwide, Inc.Protective tube for a medicated tampon
US7708726Apr 28, 2005May 4, 2010Kimberly-Clark Worldwide, Inc.Dosage form cap for an applicator
US7744556Mar 25, 2005Jun 29, 2010Kimberly-Clark Worldwide, Inc.Delivery tube assembly for an applicator
US7815593Jan 12, 2007Oct 19, 2010Peter James Brian LambDevice for introducing an object into a vagina with sanitary finger mounting means
US7846171May 27, 2004Dec 7, 2010C.R. Bard, Inc.Method and apparatus for delivering a prosthetic fabric into a patient
US7919453Mar 25, 2005Apr 5, 2011Kimberly-Clark Worldwide, Inc.Dosage cap assembly for an applicator
US7993667Mar 25, 2005Aug 9, 2011Kimberly-Clark Worldwide, Inc.Methods of manufacturing a medicated tampon assembly
US8137327Jun 16, 2006Mar 20, 2012Family Health InternationalVaginal drug delivery system and method
US8221440Nov 8, 2010Jul 17, 2012C.R. Bard, Inc.Method and apparatus for delivering a prosthetic fabric into a patient
US8388996Aug 8, 2011Mar 5, 2013Kimberly-Clark Worldwide, Inc.Methods of manufacturing a medicated tampon assembly
EP0006861A1 *Jan 16, 1979Jan 23, 1980Vorhauer LabBiologically compatible tampon sponge.
EP0029708A1 *Nov 20, 1980Jun 3, 1981Vorhauer Laboratories, Ltd.Biologically compatible tampon contraceptive
EP0051709A1 *Nov 7, 1980May 19, 1982Atlantic Pharmaceutical ProductsContraceptive tampon, set of a tampon and an applicator and process for preparing the tampon
EP2352544A2 *Nov 9, 2009Aug 10, 2011Combinent Biomedical Systems, Inc.Devices and methods for treating and/or preventing diseases
WO1980000008A1 *May 24, 1979Jan 10, 1980Donald Enterprises IncContraceptive-antivenereal disease tampon
WO1997043987A1 *May 24, 1996Nov 27, 1997Mulholland Kevin JIntra-rectal drain and receptacle for fecal incontinence
WO1998016207A1 *Oct 8, 1997Apr 23, 19983X EngineeringMicro-capsule support material
WO2001056540A2 *Feb 2, 2001Aug 9, 20013X EngineeringDevice for applying active principles for pharmaceutical or cosmetic purposes
WO2011044707A1 *Oct 13, 2010Apr 21, 2011Marlafin AgApplicator for inserting an elongated object into a human or animal body orifice
Classifications
U.S. Classification604/515, 604/11, 424/431, D24/141, 604/286, 424/433
International ClassificationA61F13/26, A61F13/20, A61K9/00
Cooperative ClassificationA61F13/26, A61K9/0036
European ClassificationA61K9/00M8B, A61F13/26
Legal Events
DateCodeEventDescription
Nov 29, 1983AS02Assignment of assignor's interest
Owner name: CORNFIELD, EDWARD
Effective date: 19831107
Owner name: MEDICAL PHYSICS CORPORATION, 11212 VALLEY VIEW AVE
Nov 29, 1983ASAssignment
Owner name: MEDICAL PHYSICS CORPORATION, 11212 VALLEY VIEW AVE
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:CORNFIELD, EDWARD;REEL/FRAME:004195/0117
Effective date: 19831107